Your browser doesn't support javascript.
loading
Interleukin-4 as a therapeutic target.
Gärtner, Yvonne; Bitar, Lynn; Zipp, Frauke; Vogelaar, Christina Francisca.
Affiliation
  • Gärtner Y; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn(2)), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Bitar L; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn(2)), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Zipp F; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn(2)), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Vogelaar CF; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn(2)), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address: tineke.vogelaar@unimedizin-mainz.de.
Pharmacol Ther ; 242: 108348, 2023 02.
Article in En | MEDLINE | ID: mdl-36657567
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Dermatitis, Atopic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Dermatitis, Atopic Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Pharmacol Ther Year: 2023 Document type: Article Affiliation country: Germany Country of publication: United kingdom